Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP325028.RAeug2fviqNBhvGZiyGrzMJJEkYNOdeTAm6lRsE6gcASY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP325028.RAeug2fviqNBhvGZiyGrzMJJEkYNOdeTAm6lRsE6gcASY130_assertion type Assertion NP325028.RAeug2fviqNBhvGZiyGrzMJJEkYNOdeTAm6lRsE6gcASY130_head.
- NP325028.RAeug2fviqNBhvGZiyGrzMJJEkYNOdeTAm6lRsE6gcASY130_assertion wasGeneratedBy ECO_0000203 NP325028.RAeug2fviqNBhvGZiyGrzMJJEkYNOdeTAm6lRsE6gcASY130_provenance.
- NP325028.RAeug2fviqNBhvGZiyGrzMJJEkYNOdeTAm6lRsE6gcASY130_assertion wasDerivedFrom befree-20140225 NP325028.RAeug2fviqNBhvGZiyGrzMJJEkYNOdeTAm6lRsE6gcASY130_provenance.
- NP325028.RAeug2fviqNBhvGZiyGrzMJJEkYNOdeTAm6lRsE6gcASY130_assertion SIO_000772 17602077 NP325028.RAeug2fviqNBhvGZiyGrzMJJEkYNOdeTAm6lRsE6gcASY130_provenance.
- NP325028.RAeug2fviqNBhvGZiyGrzMJJEkYNOdeTAm6lRsE6gcASY130_assertion evidence source_evidence_literature NP325028.RAeug2fviqNBhvGZiyGrzMJJEkYNOdeTAm6lRsE6gcASY130_provenance.
- NP325028.RAeug2fviqNBhvGZiyGrzMJJEkYNOdeTAm6lRsE6gcASY130_assertion description "[To evaluate the immunological and clinical response as well as the safety of the optimized peptide telomerase reverse transcriptase p572Y (TERT572Y) presented by HLA-A*0201 in patients with advanced non-small-cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP325028.RAeug2fviqNBhvGZiyGrzMJJEkYNOdeTAm6lRsE6gcASY130_provenance.